Dasanat (Dasatinib) 20mg

Dasanat (Dasatinib) 20mg is a kinase inhibitor indicated for the treatment of

1.newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase.

2.adults with chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib.

3.adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy.

Dasatinib Dosing

1.Chronic phase CML in adults: 100 mg once daily. 

2. Accelerated phase CML, myeloid or lymphoid blast phase CML, or Ph+ ALL in adults: 140 mg once daily. 

3. Chronic phase CML and ALL in pediatrics: starting dose based on body weight. 

4. Administer orally, with or without a meal. Do not crush, cut, or chew tablets

Dasatinib side effects

The most common side effects of Dasatinib in adults and children receiving Dasatinib alone include:

● diarrhea ● tiredness ● headache ● nausea ● skin rash ● muscle pain ● shortness of breath

Dasatinib pi

For more information, please ask our customer support for the full prescription information.